Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LHX
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -2.69 0.96 0.99
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 53.17 17.93 11.70
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.63 98.35 98.97
Cash -14.91 2.51 2.95
Capex 16.15 -0.61 -0.72
Free Cash Flow -66.45 -1.15 3.44
Revenue -2.52 27.46 28.16
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -16.05 0.22 0.26
Operating Margin -23.10 0.08 0.10
ROA 78.56 < 0.005 < 0.005
ROE 80.06 0.02 < 0.005
ROIC -56.35 0.01 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LHX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LHX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LHX is permitted for members.